All University of Cambridge articles
-
NewsTB vaccine may enable elimination of the disease in cattle by reducing its spread
Vaccination not only reduces the severity of TB in infected cattle, but reduces its spread in dairy herds by 89%, research finds.
-
NewsNew and highly infectious E. coli strain resistant to powerful antibiotics
A more infectious version of the bacterium is found to have caused two outbreaks in a children’s hospital in China.
-
NewsAntibiotic use is not the only driver of superbugs
Researchers have analysed the rise of antibiotic resistance over the last 20 years in the UK and Norway, highlighting that antibiotic use is not the only factor in the increase.
-
NewsResearchers redesign future mRNA therapeutics to prevent potentially harmful immune responses
Researchers have discovered that misreading of therapeutic mRNAs by the cell’s decoding machinery can cause an unintended immune response in the body, and have found a way to prevent ‘off-target’ immune responses.
-
NewsNew institute to bolster global preparedness for future pandemics
The University of Hong Kong (HKU), the University of Cambridge (UCAM), and the International Vaccine Institute (IVI) have established the international headquarters of The Hong Kong Jockey Club Global Health Institute at HKU.
-
NewsGenomic surveillance needed to help fight antimicrobial resistance
An international group of researchers is calling for the potential of genomic surveillance to be harnessed to tackle antimicrobial resistance (AMR), a major global challenge.
-
NewsNew UK projects to kickstart future vaccine development awarded £25m
Three UK projects designed to build our understanding of viruses and how the immune system reacts to different challenges will share £25m in new funding from UKRI.
-
NewsVulnerability to different COVID-19 mutations depends on previous infections and vaccination
A person’s immune response to variants of SARS-CoV-2 depends on their previous exposure – and differences in the focus of immune responses will help scientists understand how to optimise vaccines in the future to provide broad protection.
-
NewsResearchers to benefit from £18 million investment in world-class frontier bioscience
Researchers at The University of Warwick are among four world-class teams receiving a share of £18 million to pursue transformational bioscience research programmes.
-
NewsNew vaccine technology could protect from future viruses and variants
Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals.
-
NewsAntiviral drug linked to SARS-CoV-2 mutations
Researchers have uncovered a link between an antiviral drug for COVID-19 infections called molnupiravir and a pattern of mutations in the SARS-CoV-2 virus.
-
NewsScientists ID what makes some gut bacteria threaten neonatal babies
Researchers have identified what makes some strains of gut bacteria life-threatening in pre-term babies.
-
NewsEarly toilets reveal dysentery in Old Testament Jerusalem
A new analysis of ancient faeces taken from two Jerusalem latrines dating back to the biblical Kingdom of Judah has uncovered traces of a single-celled microorganism Giardia duodenalis – a common cause of debilitating diarrhoea in humans.
-
NewsSystem targets and degrades viral RNA to treat Covid infection
Researchers have developed a system that directly targets and degrades the viral RNA genome, reducing infection in mice. The method could be adapted to fight off many viruses, as well as treat various diseases.
-
NewsResearchers make new optimal recommendations for fungicide resistance management
Fungicide application, while helpful in controlling plant diseases, has complicated limitations that may cost growers both peace of mind and quantity of yield. Plant pathogens which would otherwise be killed off by fungicides can evolve, developing resistance that renders the standard dose of fungicide application ineffective. Source: Maccheek ...
